Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients

Detalles Bibliográficos
Autores principales: Boekel, L, Wolbink, G J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700274/
https://www.ncbi.nlm.nih.gov/pubmed/34977601
http://dx.doi.org/10.1016/S2665-9913(21)00418-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700274/
https://www.ncbi.nlm.nih.gov/pubmed/34977601
http://dx.doi.org/10.1016/S2665-9913(21)00418-5

Ejemplares similares